Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,798.89
(
0.06%
)
News Focus
News Focus
Post# of 211
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dcaf7

Send PM Follow Ignore
Followers 3
Posts 367
Boards Moderated 0
Alias Born 12/21/2022

dcaf7

Re: None

Monday, 03/23/2026 9:35:37 AM

Monday, March 23, 2026 9:35:37 AM

Post# of 211
Freedom Capital Markets raises Black Diamond stock price target on trial data.
Published 03/23/2026, 07:04 AM
Freedom Capital Markets raised its price target on Black Diamond Therapeutics shares (NASDAQ:BDTX) to $7.00 from $6.00 while maintaining a Buy rating.
The firm cited preliminary Phase 2 objective response rate data for silevertinib in Non-Small Cell Lung Cancer released in December, which showed encouraging signs and suggested a potentially meaningful progression-free survival signal.
https://www.investing.com/news/analyst-ratings/freedom-capital-markets-raises-black-diamond-stock-price-target-on-trial-data-93CH-4574772
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BDTX News
More BDTX News